Atlas‐Based Mapping of Hepatic Fat by Sex: Results From the Lifestyle Intervention ( LION ) Study

ABSTRACT Background Hepatic proton density fat fraction (PDFF) is often reported as a whole‐liver mean, without a population reference for individual fat distribution. Purpose To construct longitudinal, sex‐specific three‐dimensional PDFF atlases and assess regional fat loss, sex differences in heterogeneity, and metabolic associations. Study Type Prospective; secondary analysis of a randomized lifestyle intervention trial. Population A total of 127 adults with obesity imaged at baseline (, 73 female [F], 54 male [M]), after an 8‐week low‐caloric diet (, 49F/32M), and after 12‐month weight maintenance (, 40F/32M). Field Strength/Sequence 3T; six‐echo chemical shift‐encoded gradient‐echo. Assessment Sex‐ and visit‐specific atlases were built by deformable registration; z ‐maps quantified voxel‐wise deviation from the matched atlas. Six heterogeneity features (standard deviation [ σ x ], coefficient of variation [CV], entropy []; z ‐ skewness, z ‐kurtosis, volume fraction z > 2) were compared between sexes and correlated, cross‐sectionally and longitudinally, with hepatocellular, glycemic, adiposity markers and triglycerides, and longitudinally with steatosis remission (PDFF < 5%). Statistical Tests Welch t‐test; Spearman correlation ( ρ ); Benjamini–Hochberg correction within each test set. Significance at adjusted p < 0.05. Results Liver PDFF decreased significantly from to in males (13.6% ± 7.0% to 6.6% ± 2.5%) and females (9.1% ± 6.2% to 5.9% ± 3.3%) with regionally non‐uniform, sex‐specific patterns. At , σ x and H were significantly higher in males and CV, z ‐skewness and z ‐kurtosis in females; at , σ x (males) and z‐skewness and z‐kurtosis (females) remained significant; no feature differed at (adjusted p = [0.583–0.953]). Cross‐sectionally, features correlated with hepatocellular, glycemic and adiposity markers, more extensively in females. Longitudinally, significant correlations were almost limited to adiposity ( V 1 to V 3 : CV × visceral fat volume in females, ρ = −0.65; CV × visceral PDFF in males, ρ = −0.67); apart from × gamma‐glutamyl transferase in females, no feature tracked hepatocellular, glycemic or steatosis remission outcomes (adjusted p = [0.051–0.999], [0.092–0.999], and [0.073–0.887]). Data Conclusion Hepatic fat loss showed spatially heterogeneous and sex‐specific patterns. Heterogeneity reflected metabolic state cross‐sectionally but mainly adiposity change longitudinally. Evidence Level 2. Technical Efficacy Stage 1.

Authors

Institutions

Publication Details

Journal
Journal of Magnetic Resonance Imaging
Published
2026-11-13
DOI
https://doi.org/10.1002/jmri.70624
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Atlas‐Based Mapping of Hepatic Fat by Sex: Results From the Lifestyle Intervention ( LION ) Study

Daniel Rueckert, Dimitrios C. Karampinos, Sophie Starck, Anna Reik et al.
Journal of Magnetic Resonance Imaging
Liver Disease Diagnosis and Treatment
article

Atlas‐Based Mapping of Hepatic Fat by Sex: Results From the Lifestyle Intervention ( LION ) Study

Daniel Rueckert, Dimitrios C. Karampinos, Sophie Starck, Anna Reik, Vasiliki Sideri‐Lampretsa, Christina Holzapfel, Carmen P.S. Blanken, Johannes Raspe, Mingming Wu, Hans Hauner, Daniela Junker, Dmitrii Seletkov, Sevgi Gokce Kafali
article en

Abstract

ABSTRACT Background Hepatic proton density fat fraction (PDFF) is often reported as a whole‐liver mean, without a population reference for individual fat distribution. Purpose To construct longitudinal, sex‐specific three‐dimensional PDFF atlases and assess regional fat loss, sex differences in heterogeneity, and metabolic associations. Study Type Prospective; secondary analysis of a randomized lifestyle intervention trial. Population A total of 127 adults with obesity imaged at baseline (, 73 female [F], 54 male [M]), after an 8‐week low‐caloric diet (, 49F/32M), and after 12‐month weight maintenance (, 40F/32M). Field Strength/Sequence 3T; six‐echo chemical shift‐encoded gradient‐echo. Assessment Sex‐ and visit‐specific atlases were built by deformable registration; z ‐maps quantified voxel‐wise deviation from the matched atlas. Six heterogeneity features (standard deviation [ σ x ], coefficient of variation [CV], entropy []; z ‐ skewness, z ‐kurtosis, volume fraction z > 2) were compared between sexes and correlated, cross‐sectionally and longitudinally, with hepatocellular, glycemic, adiposity markers and triglycerides, and longitudinally with steatosis remission (PDFF < 5%). Statistical Tests Welch t‐test; Spearman correlation ( ρ ); Benjamini–Hochberg correction within each test set. Significance at adjusted p < 0.05. Results Liver PDFF decreased significantly from to in males (13.6% ± 7.0% to 6.6% ± 2.5%) and females (9.1% ± 6.2% to 5.9% ± 3.3%) with regionally non‐uniform, sex‐specific patterns. At , σ x and H were significantly higher in males and CV, z ‐skewness and z ‐kurtosis in females; at , σ x (males) and z‐skewness and z‐kurtosis (females) remained significant; no feature differed at (adjusted p = [0.583–0.953]). Cross‐sectionally, features correlated with hepatocellular, glycemic and adiposity markers, more extensively in females. Longitudinally, significant correlations were almost limited to adiposity ( V 1 to V 3 : CV × visceral fat volume in females, ρ = −0.65; CV × visceral PDFF in males, ρ = −0.67); apart from × gamma‐glutamyl transferase in females, no feature tracked hepatocellular, glycemic or steatosis remission outcomes (adjusted p = [0.051–0.999], [0.092–0.999], and [0.073–0.887]). Data Conclusion Hepatic fat loss showed spatially heterogeneous and sex‐specific patterns. Heterogeneity reflected metabolic state cross‐sectionally but mainly adiposity change longitudinally. Evidence Level 2. Technical Efficacy Stage 1.

Journal of Magnetic Resonance Imaging
TUM Klinikum (DE), LMU Klinikum (DE), Imperial College London (GB), École Polytechnique Fédérale de Lausanne (CH), University of Bayreuth (DE), Technical University of Munich (DE), Ludwig-Maximilians-Universität München (DE)
Eli Lilly and Company, Alexander von Humboldt-Stiftung, Deutsche Forschungsgemeinschaft, Novo Nordisk
Good health and well-being
Liver Disease Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon